The Center for Stem Cell Therapeutics Imaging (http://csti.bwh.harvard.edu/) at BWH, Harvard Medical School invites applications for research fellows. Our research center is focused on developing novel biological therapies for primary and metastatic tumors. Inherently linked to the tumor therapy paradigm, we engineer biological therapies and employ genetically engineered imaging markers to image stem cell fate and monitor the therapeutic efficacy in real time in vivo.
Qualifications:No Eligibility Restrictions on Entry Level or Experienced Level. However, the successful candidate should have a PhD degree or equivalents, with experience in one or more of the following broad areas: molecular biology, stem cell biology, oncology, neurobiology, oncolytic viruses and tumor microenvironment. We offer excellent training opportunities in a collaborative research environment including genetic engineering, virology, stem cell biology, gene delivery to tumors and imaging disciplines. Candidates with high quality publications in prominent journals are strongly encouraged to apply.
CSTI holds a team-oriented and fast-paced environment that always seeks for collaboration and innovative ideas. We are a team of talented lab members continuously working on multiple projects related to several types of brain tumors. Our emphasis on translational research enables us to train the next generation of bioengineers and expand the boundaries of this exciting field. We are looking for members with interpersonal skills who could make differences in biological therapies for cancer.
Internal Number: 1
About Khalid Shah, MS PhD
Dr. Shah is the Vice Chair of Research and the Director of Center for Stem Cell Therapeutics and Imaging (CSTI) within Department of Neurosurgery at Brigham and Women’s Hospital, Harvard Medical School. He is also the Principal Faculty at Harvard Stem Cell Institute and the co-Director of the joint Center of Excellence in Biomedicine (CEBM) in Boston.
Dr. Shah and his team have pioneered major developments in the stem cell therapy field, successfully developing experimental models to understand basic cancer biology and therapeutic stem cells for cancer, particularly brain tumors. These studies have been published in a number of very high impact journals like Nature Neuroscience, PNAS, Nature Reviews Cancer, JNCI, Stem Cells and Lancet Oncology. Recently, Dr. Shah's work has caught the attention in the public domain and as such it has been highlighted in the media world-wide including features on BBC and CNN. Dr. Shah holds current positions on numerous councils, advisory and editorial boards in the fields of stem cell therapy and oncology. The work from his laboratory has resulted in the formation of a biotech company whose main objective is the clinical translation of therapeutic stem cells in brain tumor patients.